The Effects of Baclofen on Chronic Tinnitus Induced By Acoustic Trauma

About this item

Title

The Effects of Baclofen on Chronic Tinnitus Induced By Acoustic Trauma

Content partner

University of Otago

Collection

Otago University Research Archive

Description

Tinnitus is characterised by a phantom ringing in the ear. Approximately twelve million Americans experience tinnitus in a form severe enough to require medical attention. Despite this prevalence there is no effective treatment available due to the uncertain pathophysiology underlining tinnitus. Acoustic trauma is the most common cause of tinnitus and is often associated with neuronal hyperactivity in the central auditory system. Hence any drug that increases GABAergic neurotransmission withi...

Read more

Format

Research paper

Research format

Scholarly text / Thesis

Thesis level

Masters

Date created

2011

Creator

Vagal, Shweta

URL

https://hdl.handle.net/10523/2020

Related subjects

tinnitus / baclofen

What is the copyright status of this item?

All Rights Reserved

This item is all rights reserved, which means you'll have to get permission from University of Otago before using it.

More Information

University of Otago has this to say about the rights status of this item:

All items in OUR Archive are provided for research purposes and private study and are protected by copyright with all rights reserved unless otherwise indicated.

What can I do with this item?

You must always check with University of Otago to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying

You are not allowed to adapt or remix this item into any other works.

No commercial use

You may not use this item commercially.